Related Experiment Video
Updated: Jun 18, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
Published on: November 23, 2013
Atypical Presentation of Anti-NMDAR Encephalitis in an Elderly Male With Dominated Memory Impairment From Damascus
Hamza Warda1, Ola Emad Alasmar2, Abdulkareem Muhammad Wardeh3,4
1Department of Internal Medecine Homs University Hospital Homs Syria.
Abstract:
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is a rare but serious autoimmune disorder that is typically characterized by a broad spectrum of psychiatric and neurological symptoms. In the academic literature, memory deficits often occur alongside psychiatric symptoms, seizures, motor dysfunctions, and other cognitive issues; it is rare to find it dominated by memory impairment with only one previous seizure. We present a unique presentation of anti-NMDAR encephalitis in a 70-year-old Middle Eastern male patient who primarily exhibited memory impairment along with one unrepeated recent seizure. The patient's initial clinical picture did not align with the classic presentation of anti-NMDAR encephalitis, which often includes prominent psychiatric symptoms and neurological features of motor dysfunction. However, brain magnetic resonance imaging (MRI), electroencephalography (EEG), and the presence of anti-NMDAR antibodies in the cerebrospinal fluid support the diagnosis. Physicians should be aware to consider anti-NMDAR encephalitis in patients with memory impairment and a single previous seizure, even in the absence of typical psychiatric or neurological features.
More Related Videos
07:20A Simple Cell-based Immunofluorescence Assay to Detect Autoantibody Against the N-Methyl-D-Aspartate (NMDA) Receptor in Blood
Published on: January 9, 2018
08:20Hippocampal Neuronal Cultures to Detect and Study New Pathogenic Antibodies Involved in Autoimmune Encephalitis
Published on: June 2, 2022
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Arboviral Encephalitis
Encephalitis l: Introduction
Encephalitis ll: Pathophysiology
Alzheimer Disease l: Introduction
Dementia l: Introduction